Nagpur: The latest 19-19 Covid data released by the state government on August 18 shows that five of the six districts that have less than 10 patients in care are from Vidarbha.
The remaining six districts in Vidarbha are among nine districts in the state that have less than 100 patients in care.
It shows that Vidarbha is in a very good position compared to other parts of Maharashtra in terms of Covid management, experts said.
Data shows that 3.31 lakh patients are under treatment in the state, with only 2,614 of them in institutional quarantine while others in house isolation.
Vidarbha only has 313 patients, which is 0.09% of the total patient lacking treatment in the state.
This shows that the majority of hospital beds in the area are empty.
Rural areas in Vidarbha where schools reopened about a month of back not reported Spike in the Covid-19 case between the children’s or overall population.
According to the expert doctor, the conditions in Vidarbha are relatively better than other parts of the country because the second wave of Covid-19 starts earlier at Vidarbha.
“The second wave began in mid-February in Vidarbha while in the other section it began in mid-March.
When we started earlier, we handled it earlier,” said an infectious disease specialist Dr.
Nitin Shinde.
Shops and markets in all regional districts have been permitted to function until 10pm.
The market opening may bring a fairly large surge in new cases but it is normal, experts said.
“We expect a small surge in a new case.
But as far as the number of new cases is controlled, this surge is natural and acceptable,” said a senior member of the Covid Divisional Task Force.
Vaccination will play a major role in infection control.
In accordance with the latest data, more than 50% of the eligible population in Vidarbha (18+) has received at least one dose of vaccine when approaching 14% has received both of these doses.
Accelerating vaccination will not only control serious diseases and hospitalization but also reduce the possibility of mutations and further viruses will get a limited scope for doubling, experts said.